Clinical trials: Allergic Sensitization

Allergic Rhinitis/Rhinoconjunctivitis +-Intermittent Asthma, Sensitization Against Betula Alba (Birch) Pollen

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

• Completed
• Age: 12 to 70 years
• Phase 3
• Injection or infusion

Specific immunotherapy for IgE mediated sensitization to birch pollen. Long-term study to assess safety and efficacy of Depigoid(R)Birch 5000 - a modified pollen extract of Betula alba (Birch) - versus placebo.

Trial name

NCT01694836

Testing

s.c. injection

Where

2 sites in Germany

Volunteers

634 people

Sponsor

Leti Pharma GmbH